We found a higher incidence of IK6, the most common protein produced by IKZF1 deletion in B-ALL patients in the high CRLF2 expression group (31% vs 8.3%, P = 0.019) (Supplementary Table 1). This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.